Atlas Trials

Xia Yi

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xia Yi

RecordFirmDate
A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL (NCT06573645)Xia Yi2024-08-23

Track Xia Yi automatically

Every clearance here is in the API, with alerts when new ones post.